Testing effectiveness (Phase 2)Ended earlyNCT01925950
What this trial is testing
Study of orBec® as Monotherapy in the Treatment of Patients With Upper GI Symptoms Caused by Chronic Graft Versus Host Disease (GVHD)
Who this might be right for
Chronic Gastrointestinal Graft vs Host Disease
Soligenix 2